BI-1347
CAS No. 2163056-91-3
BI-1347 ( BI1347 )
Catalog No. M13451 CAS No. 2163056-91-3
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 72 | In Stock |
|
10MG | 115 | In Stock |
|
25MG | 228 | In Stock |
|
50MG | 417 | In Stock |
|
100MG | 614 | In Stock |
|
500MG | 1287 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-1347
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
-
DescriptionBI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM; BI-1347 shows tumor growth inhibition in an in vivo xenograft model, BI-1347 is an excellent small molecule tool inhibitor for testing biological hypotheses in vitro and in vivo.
-
SynonymsBI1347
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2163056-91-3
-
Formula Weight356.43
-
Molecular FormulaC22H20N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 120 mg/mL (336.68 mM), Need ultrasonic and warming ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(N(C)C)CN1N=CC(C2=CC=C(C3=CN=CC4=C3C=CC=C4)C=C2)=C1
-
Chemical Name2-(4-(4-(isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CDK5 inhibitor 20-22...
CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9.
-
TBB
TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).
-
Alsteropaullone
Alsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM.